Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,727 | 686 | 98.9% |
| Education | $120.22 | 17 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,168 | 152 | $0 (2024) |
| Amgen Inc. | $1,419 | 94 | $0 (2024) |
| ABBVIE INC. | $1,252 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,044 | 67 | $0 (2024) |
| Lilly USA, LLC | $701.05 | 42 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $412.87 | 22 | $0 (2021) |
| Allergan, Inc. | $369.25 | 33 | $0 (2020) |
| PFIZER INC. | $305.21 | 21 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $281.29 | 20 | $0 (2023) |
| Amarin Pharma Inc. | $256.68 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $973.51 | 42 | ABBVIE INC. ($367.50) |
| 2023 | $1,078 | 57 | Novo Nordisk Inc ($260.60) |
| 2022 | $1,183 | 69 | Novo Nordisk Inc ($248.02) |
| 2021 | $1,497 | 97 | AbbVie Inc. ($341.26) |
| 2020 | $1,671 | 112 | Amgen Inc. ($503.51) |
| 2019 | $1,283 | 106 | Novo Nordisk Inc ($290.95) |
| 2018 | $1,140 | 97 | Novo Nordisk Inc ($334.10) |
| 2017 | $2,022 | 123 | Boehringer Ingelheim Pharmaceuticals, Inc. ($358.91) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: DIABETES | ||||||
| 10/17/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $43.35 | General |
| Category: Durable Pump | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Biological | ||||||
| 08/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Obesity | ||||||
| 07/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Biological | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: DIABETES | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Diabetes Care | ||||||
| 05/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes Care | ||||||
| 05/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,386 | 1,554 | $302,680 | $124,600 |
| 2022 | 12 | 1,348 | 1,525 | $290,095 | $115,472 |
| 2021 | 13 | 1,066 | 1,212 | $250,529 | $96,106 |
| 2020 | 18 | 1,682 | 1,903 | $401,447 | $116,911 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 281 | 281 | $110,995 | $40,583 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 290 | 393 | $94,320 | $39,533 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 168 | $27,720 | $10,863 | 39.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 34 | 34 | $13,430 | $9,599 | 71.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 121 | 122 | $10,980 | $8,772 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 125 | 126 | $8,820 | $4,280 | 48.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 41 | 43 | $7,095 | $3,250 | 45.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 249 | 253 | $15,180 | $2,640 | 17.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 13 | 13 | $4,810 | $2,391 | 49.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $2,380 | $1,155 | 48.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 22 | $3,960 | $991.62 | 25.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 27 | $1,890 | $295.55 | 15.6% |
| 90471 | Administration of vaccine | Office | 2023 | 14 | 14 | $980.00 | $223.44 | 22.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 24 | $120.00 | $23.42 | 19.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 275 | 275 | $108,625 | $40,672 | 37.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 352 | $84,480 | $33,188 | 39.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 250 | $41,250 | $16,072 | 39.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 125 | 125 | $11,250 | $8,427 | 74.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 125 | 125 | $8,750 | $4,178 | 47.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $5,530 | $3,893 | 70.4% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $4,140 | $3,001 | 72.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 241 | 245 | $14,700 | $2,578 | 17.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $2,310 | $1,118 | 48.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,880 | $921.90 | 32.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 16 | $2,880 | $778.56 | 27.0% |
About Dr. Nina Safa, MD
Dr. Nina Safa, MD is a Internal Medicine healthcare provider based in Fair Lawn, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942357595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nina Safa, MD has received a total of $10,848 in payments from pharmaceutical and medical device companies, with $973.51 received in 2024. These payments were reported across 703 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($10,727).
As a Medicare-enrolled provider, Safa has provided services to 5,482 Medicare beneficiaries, totaling 6,194 services with total Medicare billing of $453,090. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fair Lawn, NJ
- Active Since 01/05/2007
- Last Updated 05/11/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942357595
Products in Payments
- JARDIANCE (Drug) $1,053
- VRAYLAR (Drug) $908.70
- Ozempic (Drug) $801.55
- Saxenda (Drug) $496.66
- Repatha (Biological) $353.19
- Prolia (Biological) $340.06
- Aimovig (Biological) $328.11
- LINZESS (Drug) $267.87
- Livalo (Drug) $266.45
- Vascepa (Drug) $256.68
- EVENITY (Biological) $238.69
- Rybelsus (Drug) $232.29
- TRULICITY (Drug) $221.41
- Victoza (Drug) $215.54
- MOUNJARO (Drug) $202.54
- UBRELVY (Drug) $196.48
- Trintellix (Drug) $188.51
- JANUVIA (Drug) $181.51
- FARXIGA (Drug) $167.00
- BELSOMRA (Drug) $161.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fair Lawn
Joshua Balog, M.d, M.D
Internal Medicine — Payments: $17,629
Dr. Walid Elkhalili, Md, MD
Internal Medicine — Payments: $16,179
Mira Upadhyaya, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $9,548
Dr. Mark Reyn, Md, MD
Internal Medicine — Payments: $8,475
Dr. Basel Batarseh, Md, MD
Internal Medicine — Payments: $7,812
Nina Logvinenko, M.d, M.D
Internal Medicine — Payments: $7,043